HIV Drug and Liver Damage: A Case Report
Author Information
Author(s): Lapadula Giuseppe, Izzo Ilaria, Costarelli Silvia, Cologni Giuliana, Bercich Luisa, Casari Salvatore, Gambarotti Marco, Torti Carlo
Primary Institution: Institute of Infectious and Tropical Diseases, University of Brescia, Italy
Hypothesis
Is there a link between dideoxynucleoside HIV reverse transcriptase inhibitors and hepatotoxicity?
Conclusion
The case suggests that stavudine may cause liver damage even without other signs of toxicity.
Supporting Evidence
- The patient had elevated liver enzymes while on stavudine.
- Liver biopsy showed signs of drug-related liver damage.
- Liver function improved after discontinuing stavudine.
Takeaway
A woman taking a specific HIV drug had serious liver problems, but her liver got better when she stopped taking that drug.
Methodology
The case involved a detailed medical history, laboratory tests, and a liver biopsy.
Potential Biases
Potential bias due to the subjective nature of case reporting.
Limitations
The findings are based on a single case, limiting generalizability.
Participant Demographics
43-year-old HIV-positive woman.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website